article · Clinical and Experimental Dental Research
OBJECTIVES: This study investigated the synergistic effects of gingival stem cell conditioned media (GSC-CM) and low-level laser therapy (LLLT) on stimulating PDLSCs, explicitly focusing on the molecular basis of enhancing the Wnt and TGF-β signaling pathways. MATERIAL AND METHODS: PDLSCs were isolated and GSC-CM were prepared and characterized. Five groups were utilized: control, osteogenic induction medium (positive control), GSC-CM, LLLT (980 nm, 1.5 J/cm²), and a combination of GSC-CM with LLLT. Cell viability was assessed using the MTT assay on Days 1, 2, and 3. Osteogenic differentiation of PDLSCs was assessed using mineralization assays employing Alizarin Red staining, and molecular analyses of osteogenic markers (RUNX2, ALP, OCN) and signaling-related genes (CTNNβ1, TGFβ1) conducted via RT‒PCR. RESULTS: The findings revealed that the dual application of GSC-CM and LLLT significantly enhanced cell viability and osteogenic differentiation of PDLSCc compared to the effects of the individual treatment modalities. Moreover, the study revealed elevated expression levels of osteogenic markers across all the experimental groups, specially the combination group, which showed the highest levels. Significantly, the combination treatment group displayed superior outcomes in this regard. The results also suggest potential activation of Wnt/β-catenin and TGF-β signaling components. CONCLUSIONS: This study highlights the significant effects of using GSC-CM and LLLT to improve PDLSC survival and osteogenic differentiation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/cre2.70151
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.